Patents by Inventor Ved Pathak

Ved Pathak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 2-AMINO--5-SUBSTITUTED PYRIMIDINE INHIBITORS
    Publication number: 20080027070
    Abstract: Compounds having the general structure (A) are provided. The compounds of the invention are capable of inhibiting kinases, such as members of the Src kinase family, Vegfr and various other specific receptor and non-receptor kinases.
    Type: Application
    Filed: July 2, 2007
    Publication date: January 31, 2008
    Applicant: TargeGen, Inc.
    Inventors: Glenn Noronha, Jianguo Cao, Colleen Gritzen, Chi Ching Mak, Andrew McPherson, Ved Pathak, Joel Renick, Richard Soll, Binqi Zeng, Elena Dneprovskaia
  • Bi-aryl meta-pyrimidine inhibitors of kinases
    Publication number: 20070259904
    Abstract: The invention provides biaryl meta-pyrimidine compounds having the general structure (A). The pyrimidine compounds of the invention are capable of inhibiting kinases, such as members of the Jak kinase family, and various other specific receptor and non-receptor kinases.
    Type: Application
    Filed: April 26, 2007
    Publication date: November 8, 2007
    Applicant: TargeGen, Inc.
    Inventors: Glenn Noronha, Chi Mak, Jianguo Cao, Joel Renick, Andrew McPherson, Binqi Zeng, Ved Pathak, Daniel Lohse, John Hood, Richard Soll
  • Bi-aryl meta-pyrimidine inhibitors of kinases
    Publication number: 20070191405
    Abstract: The invention provides biaryl meta-pyrimidine compounds having the general structure (A). The pyrimidine compounds of the invention are capable of inhibiting kinases, such as members of the Jak kinase family, and various other specific receptor and non-receptor kinases.
    Type: Application
    Filed: October 26, 2006
    Publication date: August 16, 2007
    Applicant: TargeGen, Inc.
    Inventors: Glenn Noronha, Chi Mak, Jianguo Cao, Joel Renick, Andrew McPherson, Binqi Zeng, Ved Pathak, Daniel Lohse, John Hood, Richard Soll
  • Thiazole inhibitors targeting resistant kinase mutations
    Publication number: 20070161645
    Abstract: A compound is provided, having the general structure (A): wherein A is an aryl or heteroaryl group, Y is a hydrophbic linking moiety, and L is a substitutent. The compound (A) can be used for treatment of various angiogenic-associated or hematologic disorders, such as myeloproliferative disorders in patients who do not respond to kinase-inhibition therapy that comprises administering currently used medications.
    Type: Application
    Filed: October 31, 2006
    Publication date: July 12, 2007
    Applicant: TargeGen, Inc.
    Inventors: Glenn Noronha, Jianguo Cao, Binqi Zeng, Chi Mak, Andrew McPherson, Joel Renick, Ved Pathak, Chun Chow, Moorthy Palanki, Richard Soll, Daniel Lohse, John Hood, Elena Dneprovskaia
  • Six membered heteroaromatic inhibitors targeting resistant kinase mutations
    Publication number: 20070149508
    Abstract: A compound is provided, having the general structure (A): wherein A is an (un)substituted aryl or (un)substituted heteroaryl moiety, G is N, CH, or CR, R is an unsubstituted or substituted lower alkyl, Y is a hydrophobic linking moiety, and L is a substitutent as defined. The compound (A) can be used for treatment of various angiogenic and hematological-associated disorders, such as myeloproliferative disorder in patients who do not respond to kinase-inhibition therapy that comprises administering approved medications.
    Type: Application
    Filed: October 31, 2006
    Publication date: June 28, 2007
    Applicant: TargeGen, Inc.
    Inventors: Glenn Noronha, Jianguo Cao, Binqi Zeng, Chi Mak, Andrew McPherson, Joel Renick, Ved Pathak, Chun Chow, Moorthy Palanki, Richard Soll, Daniel Lohse, John Hood, Elena Dneprovskaia
  • Pyrimidine inhibitors of kinases
    Publication number: 20060247250
    Abstract: The invention provides pyrimidine compounds having formula A. The pyrimidine compounds of the invention are capable of inhibiting kinases, such as members of the Src kinase family, and various other specific receptor and non-receptor kinases.
    Type: Application
    Filed: March 15, 2006
    Publication date: November 2, 2006
    Applicant: TargeGen, Inc.
    Inventors: Jianguo Cao, Richard Soll, Glenn Noronha, Kathy Barrett, Colleen Gritzen, John Hood, Chi Mak, Andrew McPherson, Ved Pathak, Joel Renick, Ute Splittgerber, Binqi Zeng
  • Non-peptide GnRH agents, pharmaceutical compositions and methods for their use
    Publication number: 20050250846
    Abstract: Non-peptide GnRH agents capable of inhibiting the effect of gonadotropin-releasing hormone are described. Such compounds and their pharmaceutically acceptable salts, prodrugs, and active metabolites are suitable for treating mammalian reproductive disorders and steroid hormone-dependent tumors as well as for regulating fertility, where suppression of gonadotropin release is indicated. Methods for synthesizing the compounds and intermediates useful in their preparation are also described.
    Type: Application
    Filed: June 28, 2005
    Publication date: November 10, 2005
    Inventors: Mark Anderson, Lance Christie, Quyen-Quyen Do, Yufeng Hong, Haitao Li, Ranjan Rajapakse, Eric Sun, Eileen Tompkins, Jun Feng, Ved Pathak
  • Benzotriazine inhibitors of kinases
    Publication number: 20050245524
    Abstract: The invention provides benzotriazine compounds having formula (I). The benzotriazine compounds of the invention are capable of inhibiting kinases, such members of the Src kinase family, and various other specific receptor and non-receptor kinases.
    Type: Application
    Filed: April 7, 2005
    Publication date: November 3, 2005
    Applicant: TargeGen, Inc.
    Inventors: Glenn Noronha, Kathy Barrett, Jianguo Cao, Colleen Gritzen, Xianchang Gong, John Hood, Chi Mak, Andrew McPherson, Ved Pathak, Joel Renick, Richard Soll, Ute Splittgerber, Wolfgang Wrasdilo, Ningning Zhao, Elena Dneprovskaia